Verve Therapeutics
Francis Wong is an associate scientist at Verve Therapeutics, with expertise in molecular biology techniques and NGS platforms. Prior to joining Verve, he worked at Vertex Pharmaceuticals, where he worked on developing gene-editing therapies based on CRISPR/Cas9 mechanisms targeting Duchenne’s Muscular Dystrophy. He received his M.S. in Physiology from McGill University while researching the effects of particulate matter on respiratory health.
This person is not in any teams
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.